A database study of the safety and effectiveness of daily growth hormone in treating more than 80,000 children with growth disorders worldwide: a plain language summary of publication
Summary Researchers looked at data from the largest and longest-running database of children with growth disorders who were treated with daily injections of a brand of growth hormone called Genotropin . The researchers used these data to better understand the safety and effectiveness of daily growth...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-08-01
|
| Series: | Therapeutic Advances in Endocrinology and Metabolism |
| Online Access: | https://doi.org/10.1177/20420188251345556 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849234346476568576 |
|---|---|
| author | Mohamad Maghnie Michael B. Ranke Mitchell E. Geffner Elpis Vlachopapadopoulou Lourdes Ibáñez Martin Carlsson Wayne Cutfield Raoul Rooman Roy Gomez Michael P. Wajnrajch Agnès Linglart Renata Stawerska Peter E. Clayton Feyza Darendeliler Anita C. S. Hokken-Koelega Reiko Horikawa Toshiaki Tanaka Helmuth-Günther Dörr Michel Polak Adda Grimberg |
| author_facet | Mohamad Maghnie Michael B. Ranke Mitchell E. Geffner Elpis Vlachopapadopoulou Lourdes Ibáñez Martin Carlsson Wayne Cutfield Raoul Rooman Roy Gomez Michael P. Wajnrajch Agnès Linglart Renata Stawerska Peter E. Clayton Feyza Darendeliler Anita C. S. Hokken-Koelega Reiko Horikawa Toshiaki Tanaka Helmuth-Günther Dörr Michel Polak Adda Grimberg |
| author_sort | Mohamad Maghnie |
| collection | DOAJ |
| description | Summary Researchers looked at data from the largest and longest-running database of children with growth disorders who were treated with daily injections of a brand of growth hormone called Genotropin . The researchers used these data to better understand the safety and effectiveness of daily growth hormone treatment. Researchers showed that daily growth hormone treatment: ○ Increased the children’s heights, measured after 1 year of treatment. This was seen for all of the growth disorders studied. ○ Increased growth in children of different ages, with higher growth seen in children who had begun treatment before they started puberty. ○ Allowed short children to reach an adult height within the normal range. This was true even for children who did not begin treatment until early adolescence. ○ Was safe. Only a very small percentage (3%) of children had any side effects related to growth hormone treatment, the most common of which was headaches. When children reach the end of puberty, their growth plates close and they are unable to grow any taller. Once this happens, growth hormone treatment cannot increase their growth further and treatment should be stopped. The purpose of this plain language summary is to help you to understand the findings from recent research. Somatropin is used to treat the conditions under study that are discussed in this summary. Approval varies by country; please check with your local healthcare provider for more details. The results of this study may differ from those of other studies. Health professionals should make treatment decisions based on all available evidence and not on the results of a single study. |
| format | Article |
| id | doaj-art-8eec64e7de474c5ab070a48cbf71fdbe |
| institution | Kabale University |
| issn | 2042-0196 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Therapeutic Advances in Endocrinology and Metabolism |
| spelling | doaj-art-8eec64e7de474c5ab070a48cbf71fdbe2025-08-20T04:03:12ZengSAGE PublishingTherapeutic Advances in Endocrinology and Metabolism2042-01962025-08-011610.1177/20420188251345556A database study of the safety and effectiveness of daily growth hormone in treating more than 80,000 children with growth disorders worldwide: a plain language summary of publicationMohamad Maghnie0Michael B. Ranke1Mitchell E. Geffner2Elpis Vlachopapadopoulou3Lourdes Ibáñez4Martin Carlsson5Wayne Cutfield6Raoul Rooman7Roy Gomez8Michael P. Wajnrajch9Agnès Linglart10Renata Stawerska11Peter E. Clayton12Feyza Darendeliler13Anita C. S. Hokken-Koelega14Reiko Horikawa15Toshiaki Tanaka16Helmuth-Günther Dörr17Michel Polak18Adda Grimberg19Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Genova, ItalyDepartment of Pediatric Endocrinology, University Children’s Hospital, Tübingen, GermanyDepartment of Pediatrics, The Saban Research Institute, Children’s Hospital Los Angeles, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USADepartment of Endocrinology, Growth and Development, Children’s Hospital P. & A. Kyriakou, Athens, GreeceCentro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III (Biomedical Research Center for Diabetes and Associated Metabolic Diseases, Carlos III Health Institute), Madrid, SpainInflammation and Immunology, Pfizer Inc., New York, NY, USAPaediatric Endocrinology, Liggins Institute, University of Auckland, Auckland, New ZealandPendoCon, Putte, BelgiumPfizer Biopharmaceuticals Group, Pfizer Pte Ltd, Singapore, SingaporeDepartment of Pediatrics, New York University Grossman School of Medicine, New York, NY, USAAPHP, Reference Center for Rare Diseases of Calcium and Phosphate Metabolism, and Filière OSCAR, endo ERN and ERN BOND, Paris, FranceDepartment of Paediatric Endocrinology, Medical University of Lodz, Lodz, PolandDevelopmental Biology and Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UKPediatric Endocrinology Unit, İstanbul Faculty of Medicine, İstanbul, TurkeyDepartment of Pediatrics, Subdivision of Endocrinology, Erasmus University Medical Center, Rotterdam, The NetherlandsDivision of Endocrinology and Metabolism, National Center for Child Health and Development, Tokyo, JapanTanaka Growth Clinic, Tokyo, JapanDivision of Pediatric Endocrinology, Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, GermanyPaediatric Endocrinology, Gynaecology and Diabetology Department, Hôpital Universitaire Necker Enfants Malades, Université de Paris Cité (Necker Children’s University Hospital, University of Paris City), Paris, FranceDivision of Pediatric Endocrinology and Diabetes, Children’s Hospital of Philadelphia, Philadelphia, PA, USASummary Researchers looked at data from the largest and longest-running database of children with growth disorders who were treated with daily injections of a brand of growth hormone called Genotropin . The researchers used these data to better understand the safety and effectiveness of daily growth hormone treatment. Researchers showed that daily growth hormone treatment: ○ Increased the children’s heights, measured after 1 year of treatment. This was seen for all of the growth disorders studied. ○ Increased growth in children of different ages, with higher growth seen in children who had begun treatment before they started puberty. ○ Allowed short children to reach an adult height within the normal range. This was true even for children who did not begin treatment until early adolescence. ○ Was safe. Only a very small percentage (3%) of children had any side effects related to growth hormone treatment, the most common of which was headaches. When children reach the end of puberty, their growth plates close and they are unable to grow any taller. Once this happens, growth hormone treatment cannot increase their growth further and treatment should be stopped. The purpose of this plain language summary is to help you to understand the findings from recent research. Somatropin is used to treat the conditions under study that are discussed in this summary. Approval varies by country; please check with your local healthcare provider for more details. The results of this study may differ from those of other studies. Health professionals should make treatment decisions based on all available evidence and not on the results of a single study.https://doi.org/10.1177/20420188251345556 |
| spellingShingle | Mohamad Maghnie Michael B. Ranke Mitchell E. Geffner Elpis Vlachopapadopoulou Lourdes Ibáñez Martin Carlsson Wayne Cutfield Raoul Rooman Roy Gomez Michael P. Wajnrajch Agnès Linglart Renata Stawerska Peter E. Clayton Feyza Darendeliler Anita C. S. Hokken-Koelega Reiko Horikawa Toshiaki Tanaka Helmuth-Günther Dörr Michel Polak Adda Grimberg A database study of the safety and effectiveness of daily growth hormone in treating more than 80,000 children with growth disorders worldwide: a plain language summary of publication Therapeutic Advances in Endocrinology and Metabolism |
| title | A database study of the safety and effectiveness of daily growth hormone in treating more than 80,000 children with growth disorders worldwide: a plain language summary of publication |
| title_full | A database study of the safety and effectiveness of daily growth hormone in treating more than 80,000 children with growth disorders worldwide: a plain language summary of publication |
| title_fullStr | A database study of the safety and effectiveness of daily growth hormone in treating more than 80,000 children with growth disorders worldwide: a plain language summary of publication |
| title_full_unstemmed | A database study of the safety and effectiveness of daily growth hormone in treating more than 80,000 children with growth disorders worldwide: a plain language summary of publication |
| title_short | A database study of the safety and effectiveness of daily growth hormone in treating more than 80,000 children with growth disorders worldwide: a plain language summary of publication |
| title_sort | database study of the safety and effectiveness of daily growth hormone in treating more than 80 000 children with growth disorders worldwide a plain language summary of publication |
| url | https://doi.org/10.1177/20420188251345556 |
| work_keys_str_mv | AT mohamadmaghnie adatabasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT michaelbranke adatabasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT mitchellegeffner adatabasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT elpisvlachopapadopoulou adatabasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT lourdesibanez adatabasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT martincarlsson adatabasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT waynecutfield adatabasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT raoulrooman adatabasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT roygomez adatabasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT michaelpwajnrajch adatabasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT agneslinglart adatabasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT renatastawerska adatabasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT petereclayton adatabasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT feyzadarendeliler adatabasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT anitacshokkenkoelega adatabasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT reikohorikawa adatabasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT toshiakitanaka adatabasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT helmuthguntherdorr adatabasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT michelpolak adatabasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT addagrimberg adatabasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT mohamadmaghnie databasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT michaelbranke databasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT mitchellegeffner databasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT elpisvlachopapadopoulou databasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT lourdesibanez databasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT martincarlsson databasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT waynecutfield databasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT raoulrooman databasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT roygomez databasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT michaelpwajnrajch databasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT agneslinglart databasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT renatastawerska databasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT petereclayton databasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT feyzadarendeliler databasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT anitacshokkenkoelega databasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT reikohorikawa databasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT toshiakitanaka databasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT helmuthguntherdorr databasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT michelpolak databasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication AT addagrimberg databasestudyofthesafetyandeffectivenessofdailygrowthhormoneintreatingmorethan80000childrenwithgrowthdisordersworldwideaplainlanguagesummaryofpublication |